Which condition contraindicates the use of a combination oral contraceptive?

The use of combination oral contraceptives, which contain both estrogen and progesterone, is contraindicated in individuals with a history of breast cancer due to the potential for estrogen to promote tumor growth. Estrogen can stimulate certain types of breast cancer cells, making the risk of recurrence or progression of cancer a significant concern. For this reason, healthcare providers typically recommend alternative forms of contraception for individuals with a history of breast cancer.

While hypertension, type 2 diabetes, and hyperlipidemia can present risks and may require careful management when considering contraceptive options, they do not categorically contraindicate the use of combination oral contraceptives in the same way a history of breast cancer does. In fact, individuals with controlled hypertension or well-managed type 2 diabetes might still be able to use these contraceptives under medical guidance. Hyperlipidemia may raise concerns, but it can often be monitored without completely discarding the option of combination contraceptives.